Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure

Isaac Giménez-Escamilla,Carlota Benedicto,Lorena Pérez-Carrillo,Marta Delgado-Arija,Irene González-Torrent,Roger Vilchez,Luis Martínez-Dolz,Manuel Portolés,Estefanía Tarazón,Esther Roselló-Lletí
DOI: https://doi.org/10.3390/antiox13030285
IF: 7.675
2024-02-26
Antioxidants
Abstract:Heart failure (HF) is a disease related to bioenergetic mitochondrial abnormalities. However, the whole status of molecules involved in the oxidative phosphorylation system (OXPHOS) is unknown. Therefore, we analyzed the OXPHOS transcriptome of human cardiac tissue by RNA-seq analyses (mRNA n = 36; ncRNA n = 30) in HF patients (ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM)) and control subjects. We detected 28 altered genes in these patients, highlighting greater deregulation in ICM. Specifically, we found a general overexpression of complex V (ATP synthase) elements, among them, ATP5I (ICM, FC = 2.04; p < 0.01), ATP5MJ (ICM, FC = 1.33, p < 0.05), and ATP5IF1 (ICM, FC = 1.81; p < 0.001), which presented a significant correlation with established echocardiographic parameters of cardiac remodeling and ventricular function as follows: left ventricular end-systolic (p < 0.01) and end-diastolic (p < 0.01) diameters, and ejection fraction (p < 0.05). We also detected an increase in ATP5IF1 protein levels (ICM, FC = 1.75; p < 0.01) and alterations in the microRNA expression levels of miR-208b-3p (ICM, FC = −1.44, p < 0.001), miR-483-3p (ICM, FC = 1.37, p < 0.01), regulators of ATP5I. Therefore, we observed the deregulation of the OXPHOS transcriptome in ICM patients, highlighting the overexpression of complex V and its relationship with cardiac remodeling and function.
biochemistry & molecular biology,chemistry, medicinal,food science & technology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the molecular state of the oxidative phosphorylation system (OXPHOS) in the cardiac tissue of patients with heart failure (HF) and its relationship with cardiac remodeling and function. Specifically, the researchers analyzed the mitochondrial OXPHOS transcriptome of heart failure patients through RNA sequencing and explored the relationship between these changes and cardiac remodeling and function. The focus of the study was on the changes in the OXPHOS system in the two most common types of HF etiologies, ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM), especially the over - expression of complex V (ATP synthase) and its association with cardiac remodeling and function. ### Research Background - Heart failure is a complex multifactorial syndrome in which the heart fails to meet the metabolic needs of the body. - Mitochondria play a crucial role in the cardiac energy supply, producing approximately 95% of the ATP required by the heart through the oxidative phosphorylation system (OXPHOS). - Abnormalities in the mitochondrial OXPHOS system and an increase in reactive oxygen species (ROS) are closely related to heart failure, but currently, there is insufficient understanding of the molecular states involved in this process. ### Research Objectives - To identify the molecular state of the OXPHOS system in the cardiac tissue of ICM and DCM patients. - To explore the relationship between these molecular changes and cardiac remodeling and function, especially the over - expression of complex V (ATP synthase) and its impact. ### Main Findings - The study found that there is a widespread over - expression of OXPHOS - related genes in HF patients, especially more significantly in ICM patients. - Multiple components of complex V (ATP synthase) are significantly over - expressed in ICM patients, such as ATP5I, ATP5IF1 and ATP5MJ. - The over - expression of these genes is significantly correlated with cardiac remodeling and function parameters (such as left ventricular end - systolic diameter, left ventricular end - diastolic diameter and ejection fraction). - In addition, changes in the expression levels of microRNAs such as miR - 208b - 3p and miR - 483 - 3p were also detected, and these microRNAs are regulators of ATP5I. ### Conclusions - This study reveals a significant dysregulation of the OXPHOS system, especially complex V (ATP synthase) in ICM patients. - These findings are helpful for understanding the role of mitochondrial dysfunction in the development of heart failure and provide potential targets for further treatment strategies.